Skip to content

BIOCEPT, INC.: 10-K filed 2020-03-27

What BIOCEPT, INC. reported in its annual report filed 2020-03-27 (fiscal FY 2019): 45 published measures, 185 facts as tagged in accession 0001564590-20-013670.

This filing

Form
10-K (annual report)
Filed
2020-03-27
Fiscal period
fiscal FY 2019
Accession
0001564590-20-013670 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOCEPT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-12-3117,732,644USD
At 2019-09-3014,520,914USD
At 2019-06-3019,904,840USD
At 2019-03-3121,891,932USD
At 2018-12-318,750,303USD
At 2018-09-3014,551,892USD
At 2018-06-308,291,310USD
At 2018-03-3114,747,827USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-12-316,532,001USD
At 2018-12-315,707,784USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-12-3111,200,643USD
At 2019-09-307,705,458USD
At 2019-06-3013,099,551USD
At 2019-03-3114,014,084USD
At 2018-12-313,042,519USD
At 2018-09-308,938,408USD
At 2018-06-302,527,568USD
At 2018-03-318,507,714USD
At 2017-12-311,296,034USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-5,713,478USD92
2019-01-01 to 2019-12-31-25,138,039USD365
2019-07-01 to 2019-09-30-5,691,762USD92
2019-04-01 to 2019-06-30-7,816,012USD91
2019-01-01 to 2019-03-31-5,916,787USD90
2018-10-01 to 2018-12-31-6,014,312USD92
2018-01-01 to 2018-12-31-24,571,601USD365
2018-07-01 to 2018-09-30-6,047,784USD92
2018-04-01 to 2018-06-30-6,153,101USD91
2018-01-01 to 2018-03-31-6,356,404USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-23,049,261USD365
2018-01-01 to 2018-12-31-22,355,218USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-12-31735,300USD365
2018-01-01 to 2018-12-31145,253USD365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2019-10-01 to 2019-12-311,783,742USD92
2019-01-01 to 2019-12-315,528,566USD365
2019-07-01 to 2019-09-301,529,262USD92
2019-04-01 to 2019-06-301,191,323USD91
2019-01-01 to 2019-03-311,024,239USD90
2018-10-01 to 2018-12-31859,526USD92
2018-01-01 to 2018-12-313,250,298USD365
2018-07-01 to 2018-09-30761,591USD92
2018-04-01 to 2018-06-30822,238USD91
2018-01-01 to 2018-03-31806,943USD90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-12-3129,662,594USD365
2018-01-01 to 2018-12-3123,777,233USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-735,300USD365
2018-01-01 to 2018-12-31-145,253USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-12-31-245,717,189USD
At 2018-12-31-220,457,578USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-10-01 to 2019-12-3129,128,632shares92
2019-01-01 to 2019-12-3120,660,894shares365
2019-07-01 to 2019-09-3023,018,235shares92
2019-04-01 to 2019-06-3020,466,224shares91
2019-01-01 to 2019-03-319,792,093shares90
2018-10-01 to 2018-12-314,209,221shares92
2018-01-01 to 2018-12-312,798,243shares365
2018-07-01 to 2018-09-302,767,440shares92
2018-04-01 to 2018-06-302,280,115shares91
2018-01-01 to 2018-03-311,911,282shares90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2019-10-01 to 2019-12-3129,128,632shares92
2019-01-01 to 2019-12-3120,660,894shares365
2019-07-01 to 2019-09-3023,018,235shares92
2019-04-01 to 2019-06-3020,466,224shares91
2019-01-01 to 2019-03-319,792,093shares90
2018-10-01 to 2018-12-314,209,221shares92
2018-01-01 to 2018-12-312,798,243shares365
2018-07-01 to 2018-09-302,759,614shares92
2018-04-01 to 2018-06-302,280,115shares91
2018-01-01 to 2018-03-311,911,282shares90

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-0.2USD/shares92
2019-01-01 to 2019-12-31-1.22USD/shares365
2019-07-01 to 2019-09-30-0.25USD/shares92
2019-04-01 to 2019-06-30-0.38USD/shares91
2019-01-01 to 2019-03-31-0.61USD/shares90
2018-10-01 to 2018-12-31-1.43USD/shares92
2018-01-01 to 2018-12-31-9.01USD/shares365
2018-07-01 to 2018-09-30-2.42USD/shares92
2018-04-01 to 2018-06-30-2.7USD/shares91
2018-01-01 to 2018-03-31-3.33USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-0.2USD/shares92
2019-01-01 to 2019-12-31-1.22USD/shares365
2019-07-01 to 2019-09-30-0.25USD/shares92
2019-04-01 to 2019-06-30-0.38USD/shares91
2019-01-01 to 2019-03-31-0.61USD/shares90
2018-10-01 to 2018-12-31-1.43USD/shares92
2018-01-01 to 2018-12-31-9.01USD/shares365
2018-07-01 to 2018-09-30-2.42USD/shares92
2018-04-01 to 2018-06-30-2.7USD/shares91
2018-01-01 to 2018-03-31-3.33USD/shares90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-01-01 to 2018-12-311,886USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-12-311,504,330USD
At 2018-12-312,739,422USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-12-31869,579USD365
2018-01-01 to 2018-12-31623,412USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-5,651,070USD92
2019-01-01 to 2019-12-31-23,056,939USD365
2019-07-01 to 2019-09-30-5,629,734USD92
2019-04-01 to 2019-06-30-5,921,322USD91
2019-01-01 to 2019-03-31-5,854,813USD90
2018-10-01 to 2018-12-31-5,938,161USD92
2018-01-01 to 2018-12-31-24,258,739USD365
2018-07-01 to 2018-09-30-6,007,983USD92
2018-04-01 to 2018-06-30-6,038,862USD91
2018-01-01 to 2018-03-31-6,273,733USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-12-3113,892,597USD
At 2018-12-316,010,881USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-01-01 to 2019-12-31249,984USD365
2018-01-01 to 2018-12-31310,976USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-12-315,558,812USD
At 2018-12-314,609,647USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-12-312,011,827USD
At 2018-12-312,039,718USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-12-313,527,078USD
At 2018-12-311,574,325USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-12-31767,986USD
At 2018-12-31587,222USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-10-01 to 2019-12-312,872,098USD92
2019-01-01 to 2019-12-3110,977,520USD365
2019-07-01 to 2019-09-302,832,735USD92
2019-04-01 to 2019-06-302,673,323USD91
2019-01-01 to 2019-03-312,599,364USD90
2018-10-01 to 2018-12-312,435,262USD92
2018-01-01 to 2018-12-3110,051,735USD365
2018-07-01 to 2018-09-302,481,916USD92
2018-04-01 to 2018-06-302,699,671USD91
2018-01-01 to 2018-03-312,434,886USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-10-01 to 2019-12-311,161,905USD92
2019-01-01 to 2019-12-314,697,022USD365
2019-07-01 to 2019-09-301,163,546USD92
2019-04-01 to 2019-06-301,148,280USD91
2019-01-01 to 2019-03-311,223,291USD90
2018-10-01 to 2018-12-311,288,957USD92
2018-01-01 to 2018-12-314,468,572USD365
2018-07-01 to 2018-09-301,089,746USD92
2018-04-01 to 2018-06-301,019,285USD91
2018-01-01 to 2018-03-311,070,584USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-12-3154,738,485shares
At 2018-12-314,629,174shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-12-31729,330USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-12-31842,452USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2019-12-315,762,627USD
At 2018-12-317,674,150USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-12-314,258,297USD
At 2018-12-314,934,728USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-12-311,980,204USD
At 2018-12-311,928,393USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-12-31296,127USD
At 2018-12-31425,961USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-25,138,039USD365
2018-01-01 to 2018-12-31-24,569,715USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-5,735,307USD92
2019-01-01 to 2019-12-31-25,259,611USD365
2019-07-01 to 2019-09-30-5,691,762USD92
2019-04-01 to 2019-06-30-7,816,012USD91
2019-01-01 to 2019-03-31-6,016,530USD90
2018-10-01 to 2018-12-31-6,014,312USD92
2018-01-01 to 2018-12-31-25,207,971USD365
2018-07-01 to 2018-09-30-6,684,154USD92
2018-04-01 to 2018-06-30-6,153,101USD91
2018-01-01 to 2018-03-31-6,356,404USD90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-10-01 to 2019-12-311,911,593USD92
2019-01-01 to 2019-12-316,970,120USD365
2019-07-01 to 2019-09-301,700,380USD92
2019-04-01 to 2019-06-301,676,310USD91
2019-01-01 to 2019-03-311,681,837USD90
2018-10-01 to 2018-12-311,632,670USD92
2018-01-01 to 2018-12-317,074,024USD365
2018-07-01 to 2018-09-301,793,720USD92
2018-04-01 to 2018-06-301,708,970USD91
2018-01-01 to 2018-03-311,938,664USD90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-2,081,100USD365
2018-01-01 to 2018-12-31-310,976USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2018-01-01 to 2018-12-311,886USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-12-31249,984USD365
2018-01-01 to 2018-12-31605,485USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2018-01-01 to 2018-12-314,517USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-09-19 to 2018-09-202,500,000USD2
2018-08-12 to 2018-08-1311,600,000USD2

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,430,366USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,952,753USD365
2018-01-01 to 2018-12-31380,899USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-31194,928USD365
2018-01-01 to 2018-12-3150,021USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-3114,838USD365
2018-01-01 to 2018-12-31601,872USD365

Inspect the source

Entity
BIOCEPT, INC. / CIK 0001044378
Captured
SEC response SHA-256
e2cd33a1599dddaf1c1158b0c135422459c9498a550077875151b7dd6db64b15

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001044378.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))